← Back to Search

Antiretroviral

PrEP screening program for HIV/AIDS (PrEPPED Trial)

N/A

Waitlist Available

Led By Ethan Cowan, MD

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days post-ed visit

Awards & highlights

PrEPPED Trial Summary

This trial seeks to expand access to and engagement in pre-exposure prophylaxis (PrEP) among high risk individuals by using an innovative delivery approach in the Emergency Department (ED).

Eligible Conditions

HIV/AIDS
Pre-Exposure Prophylaxis

PrEPPED Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days post-ed visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days post-ed visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days post-ed visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Engagement in care (Implementation Component)

Time to completion of ED PrEP screening (Implementation Component)

Secondary outcome measures

CDC Sexual Behavior Questions (CSBQ) (RCT Component)

Number of new HIV Infection (RCT Component)

Number of new STI diagnoses (RCT Component)

+3 more

PrEPPED Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: PreP Screening ProgramExperimental Treatment1 Intervention

Part 1: Targeted ED-based patients

Group II: Immediate PreP initiationExperimental Treatment2 Interventions

PreP screening program with immediate PrEP (iPrEP) initiation in the ED using a PrEP "starter pack" with facilitated linkage to care.

Group III: Out-patient care for PrEP initiationActive Control1 Intervention

PrEP screening program with referral to out-patient care for PrEP initiation

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

860 Previous Clinical Trials

524,450 Total Patients Enrolled

Ethan Cowan, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai

1 Previous Clinical Trials

21 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the ambitious objectives of this experiment?

"For the purposes of this study, which will last around 30 days post ED visit, primary outcomes are completion time for pre-exposure prophylaxis (Prep) screening and implementation. Secondary objectives include satisfaction levels assessed through Visit Rating Questionnaire (VSQ9), Centers for Disease Control and Prevention Sexual Behavior Questions (CSBQ), as well as patient adherence to PrEP regimens measured with Guidelines Regimen Information Program survey."

Answered by AI

Has recruitment of participants for this trial already commenced?

"According to the records posted on clinicaltrials.gov, applications for this trial have been closed since August 3rd 2022. The original announcement was made September 18th 2020 and no new participants are being sought at present time; however there are 288 other studies with openings right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pre-Exposure Prophylaxis in the Emergency Department

Ethan Cowan 2020. "Pre-Exposure Prophylaxis in the Emergency Department". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04429971.